In early March of 2011, the FDA strengthened the warning label on Topamax (generic name: Topiramate) due to an association between Topamax use and birth defects. Currently, Topamax is most strongly associated with oral birth defects, such as cleft lips and cleft palates. Cleft lips are fairly common birth defects in which the upper lip
Topamax lawyers are heavily advertising on the Internet regarding the link between Topamax and birth defects like cleft palates and cleft lips. To the best of my knowledge, no Topamax attorney has yet filed a Topamax birth defect lawsuit. One of the reasons why I suspect that Topamax litigation will commence so soon after Topamax
On March 4th of 2010, the FDA announced that new data showed that women who take Topamax during pregnancy are at an increased risk of giving birth to a child with a cleft lip or a cleft palate. Topamax and Topiramate (the generic equivalent of Topamax) were approved by the FDA to treat certain types
It wasn’t until March of 2011 that the FDA issued a warning that linked Topamax with cleft palate and cleft lip birth defects. But back in July of 2008, a study linked the drug to those very defects: For the study, researchers examined women who became pregnant while taking topiramate either on its own or along